Natpara FDA Approval History
FDA Approved: Yes (First approved January 23, 2015)
Brand name: Natpara
Generic name: parathyroid hormone
Dosage form: Injection
Company: NPS Pharmaceuticals, Inc.
Treatment for: Hypoparathyroidism
Natpara (parathyroid hormone) is recombinant human parathyroid hormone 1-84 indicated to control hypocalcemia in patients with hypoparathyroidism.
Development Timeline for Natpara
|Jan 23, 2015||FDA Approves Natpara (parathyroid hormone) for Hypocalcemia in Patients with Hypoparathyroidism|
|Sep 5, 2012||NPS Pharmaceuticals Expects to File Natpara BLA in Mid-2013|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.